FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 1 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,495,320 | +59.1% | 561,998 | +18.2% | 0.00% | – |
| Q2 2023 | $1,568,443 | -27.1% | 475,335 | -37.0% | 0.00% | -100.0% |
| Q1 2023 | $2,151,393 | +76271.8% | 754,886 | +95.1% | 0.00% | 0.0% |
| Q4 2022 | $2,817 | -99.9% | 386,832 | +65.3% | 0.00% | 0.0% |
| Q3 2022 | $1,893,000 | +6.8% | 234,080 | -35.4% | 0.00% | 0.0% |
| Q2 2022 | $1,773,000 | -73.5% | 362,104 | +28.0% | 0.00% | -50.0% |
| Q1 2022 | $6,688,000 | +101.6% | 282,793 | +50.8% | 0.00% | +100.0% |
| Q4 2021 | $3,317,000 | +131.6% | 187,521 | +269.5% | 0.00% | – |
| Q3 2021 | $1,432,000 | +80.8% | 50,748 | -32.9% | 0.00% | – |
| Q2 2021 | $792,000 | +34.9% | 75,583 | +51.7% | 0.00% | – |
| Q1 2021 | $587,000 | – | 49,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $32,054,000 | 14.00% |
| TRV GP IV, LLC | 2,343,154 | $18,956,000 | 11.08% |
| Logos Global Management LP | 1,950,000 | $15,776,000 | 1.94% |
| COWEN AND COMPANY, LLC | 2,347,989 | $18,995,000 | 1.82% |
| VR Adviser, LLC | 1,200,000 | $9,708,000 | 1.50% |
| RA Capital Management | 7,000,000 | $56,630,000 | 1.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,528,000 | $28,542,000 | 1.18% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $1,780,000 | 0.77% |
| RTW INVESTMENTS, LP | 3,985,910 | $32,246,000 | 0.74% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $211,000 | 0.69% |